Acute Stroke Animal Models & CRO Services

Stroke is a major cause of death and disability worldwide, with approximate 800,000 new cases in the U.S. per year. Eighty-five percent of strokes are "ischemic," due to occlusion of a brain artery, causing death of brain tissue (infarction) supplied by that artery. Acute stroke treatments are given within a few hours after stroke onset. Such treatments include thrombolytic ("clot-busting") and tissue-sparing ("neuroprotective") agents.

NeuroVasc is highly experienced in rodent (mouse and rat) models of acute focal stroke, including suture-occlusion, Chen, Tamura, and embolic methods. These models are suitable for testing of new thrombolytic and neuroprotective strategies. Endpoints of these studies include histology (infarct volume determination) and behavioral testing.

Your partner for preclinical CNS and Vascular models

Newsletter

 

Contact Us

NeuroVasc Preclinical Services, Inc.
3 Forbes Road
Lexington MA 02421

617-855-6289

info@neurovascps.com